Unaudited Financial Results
        For the 4th Quarter and Financial Year Ended 31st March 2010   (Rs. in Lakhs)
 Particulars 
3 Months ended 31/03/10
3 Months ended 31/03/09
Financial Year ended 31/03/10
Financial Year ended 31/03/09
1. (a) Net Sale/ Income from Operations 814.67 934.08 3249.82 2181.84
    (b) Other Operating Income 0 0 0 0
2. Expenditure
Increase/ Decrease in Stock in trade and WIP -22.91 -24.08 -17.74 -29.14
Consumption of RM 69.51 465.01 245.1 650.22
Purchase of traded goods 685.26 352.95 2726.7 1347.69
Employee Cost 4.92 3.16 17.1 14.83
Depreciation 8.25 7.84 33 31.39
Other Expenditure 33.59 4.45 58.06 26.09
Total  778.62 809.33 3062.22 2041.08
3. Profit from operations before other income, interest and exceptional items 36.05 124.75 187.6 140.76
4. Other Income 2.11 2.25 8.92 8.59
5. Profit before interest and exceptional items 38.16 127 196.52 149.35
6. Interest 0 0.35 0
7. Profit after interest but before exceptional items 38.16 127 196.17 149.35
8. Exceptional items 0 0 0 0
9. Profit (+)/ Loss (-) from ordinary activities before tax 38.16 127 196.17 149.35
10. Tax Expense 0 51.83 6.44 51.83
11. Net Profit (+)/ Loss (-) from Ordinary Activities after tax 38.16 75.17 189.73 97.52
12. Extraordinary Item (net of tax expenses) 0 0 0 0
13. Net Profit (+)/ Loss (-) for the period 38.16 75.17 189.73 97.52
14. Paid-up Equity Share Capital (Face Value of the Share shall be indicated) 2207.43 2207.43 2207.43 2207.43
Face Value of Equity Shares 1 1 1 1
15. Reserve excluding Revaluation Reserves as per Balance Sheet of previous year 471.51 436.73
16. Earning Per Share (EPS)
(a) Basic & Diluted EPS before Extraordinary items for the period, for the year to date and for the previous year (not to be annualised) 0.02 0.03 0.09 0.04
(b) Basic & Diluted EPS after Extraordinary items for the period, for the year to date and for the previous year (not to be annualised) 0.02 0.03 0.09 0.04
17. Public Shareholding
 - No. of shares 133507360 131507360 133507360 131507360
 - Percentage of shareholding 60.48 59.57 60.48 59.57
18. Promoters and promoter group Shareholding
    a) Pledged/ Encumbered
- Number of shares 0 0 0 0
- Percentage of shares (as a % of the total shareholding of promoter and promoter group) 0% 0% 0% 0%
- Percentage of shares (as a% of the total share capital of the company) 0% 0% 0% 0%
    b) Non-encumbered
- Number of Shares 87235200 89235200 87235200 89235200
- Percentage of shares (as a% of the total shareholding of promoter and promoter group) 100% 100% 100% 100%
- Percentage of shares (as a % of the total share capital of the company) 39.52% 40.43% 39.52% 40.43%

Quarterly Reporting Segment wise Revenue, Results and Capital Employed under Clause 41
of the Listing Agreement

 
Particulars 
3 Months ended 31/03/10
3 Months ended 31/03/09
Financial Year ended 31/03/10
Financial Year ended 31/03/09
(Net Sale/ income from each segment)
Segment Revenue
(a) Sale of Pharma & Chemical Products
680.89
360.15
2775.93
1375.19
(b) Income from Operation
124.45
551.64
436.66
755.49
(c) IT Activities
9.33
22.29
37.23
51.16
Total
814.67
934.08
3249.82
2181.84
Less : Inter Segment Revenue
0
0
0
0
Net Sales/ Income from operations
814.67
934.08
3249.82
2181.84
Segment Results
(Profit / Loss before tax and interest from each segment)
(a) Sale of Pharma & Chemical Products
29.77
110.85
151.48
128.88
(b) Income from Operation
10.79
35.98
54.14
42.98
(c) IT Activities
0.21
3.49
0.8
3.92
Less : Inter Segment Income
0
0
0
0
Less: Unallocable Expenditure
2.61
23.32
9.9
26.43
PBT
38.16
127
196.52
149.3